Clincosm LogoSign in Get a demo

nonsmall cell lung cancer

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount

Recruiting
  • Triple Negative Breast Cancer
  • Nonsmall Cell Lung Cancer
    • Rocky Mount, North Carolina
      Accellacare of Rocky Mount -Dr. Bondy
    May 26, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    Genomic Data of American Indian Patient Population

    Active, not recruiting
    • Immune Checkpoint Inhibitors
    • +6 more
    • Immunotherapy
    • Tucson, Arizona
    • +5 more
    May 8, 2023

    Breast Cancer, Nonsmall Cell Lung Cancer Trial in Beijing ([14C]GB491)

    Completed
    • Breast Cancer
    • Nonsmall Cell Lung Cancer
    • Beijing, Beijing, China
      Beijing GoBroad Boren Hospital
    May 5, 2023

    Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for

    Recruiting
    • Metastatic Solid Tumor
    • +3 more
    • 1.0% IP-001 for Injection
    • Bordeaux, France
    • +9 more
    Jan 26, 2023

    Nonsmall Cell Lung Cancer Trial in Anaheim, Beverly Hills, Aurora (HS-10296)

    Active, not recruiting
    Has Results
    • Nonsmall Cell Lung Cancer
    • Anaheim, California
    • +9 more
    Dec 27, 2022

    KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (JDQ443, trametinib, Ribociclib)

    Recruiting
    • KRAS G12C Mutant Solid Tumors
    • +10 more
    • Boston, Massachusetts
    • +5 more
    Jan 11, 2023

    NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

    Active, not recruiting
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 3, 2023

    Cancer, Tumor, Solid, Nonsmall Cell Lung Cancer Trial in United States (HMBD-002, Pembrolizumab)

    Recruiting
    • Cancer
    • +6 more
    • Duarte, California
    • +6 more
    Dec 26, 2022

    Nonsmall Cell Lung Cancer, Performance Status Trial in Winston-Salem (Pembrolizumab, Carboplatin, Paclitaxel)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Performance Status
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Dec 19, 2022

    Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)

    Active, not recruiting
    • Nonsmall Cell Lung Cancer
    • NSCLC
    • NovoTTF-200T
    • Immune checkpoint inhibitors or docetaxel
    • Birmingham, Alabama
    • +123 more
    Oct 13, 2022

    Carcinoma,Non-Small-Cell Lung, Lung Carcinomas, Non-Small-Cell, Non-small-cell Lung Carcinoma Trial in Worldwide (Pemetrexed,

    Active, not recruiting
    • Carcinoma，Non-Small-Cell Lung
    • +3 more
    • Albury, New South Wales, Australia
    • +192 more
    Sep 19, 2022

    Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

    Not yet recruiting
    • Cancer
    • +5 more
    • (no location specified)
    Aug 18, 2022

    NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +4 more
    • Mobile, Alabama
    • +14 more
    May 12, 2022

    Nonsmall Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab)

    Not yet recruiting
    • Nonsmall Cell Lung Cancer
    • New York, New York
      Columbia University Irving Medical Center
    Apr 29, 2022

    Stage IV NSCLC, Targeted Therapy, Nonsmall Cell Lung Cancer Trial in Boston (POISE)

    Not yet recruiting
    • Stage IV Non-small Cell Lung Cancer
    • +7 more
    • POISE
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 13, 2022

    Nonsmall Cell Lung Cancer Trial in Goyang-Si (Lorlatinib)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Goyang-Si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Apr 4, 2022

    EGFR Gene Mutation, Nonsmall Cell Lung Cancer Trial in Washington, Hackensack (Dasatinib, Osimertinib)

    Active, not recruiting
    • EGFR Gene Mutation
    • Nonsmall Cell Lung Cancer
    • Washington, District of Columbia
    • +1 more
    Jan 9, 2022

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer Stage Trial in Winston-Salem (Breath Collection, Saliva Collection, Blood

    Terminated
    Has Results
    • Nonsmall Cell Lung Cancer
    • Nonsmall Cell Lung Cancer Stage
    • Breath Collection
    • +5 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Oct 7, 2021

    Nonsmall Cell Lung Cancer Trial in Burlington (Exercise)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Exercise
    • Burlington, Vermont
      University of Vermont College of Medicine
    Oct 4, 2021

    Nonsmall Cell Lung Cancer, Solid Tumor, Adult Trial in Guanzhou (TCR-T cells)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Solid Tumor, Adult
    • TCR-T cells
    • Guanzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Sep 19, 2021

    Carcinoma, Non-Small Cell Lung, NSCLC, Non-Small-Cell Lung Carcinoma Trial (Capmatinib)

    Available
    • Carcinoma, Non-Small Cell Lung
    • +3 more
    • (no location specified)
    Aug 31, 2021

    Carcinoma, Non-Small-Cell-Lung, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (European Organization for Research and

    Completed
    • Carcinoma, Non-Small-Cell-Lung
    • +2 more
    • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30
    • +5 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 6, 2021

    Nonsmall Cell Lung Cancer Trial in Fuzhou (Apatinib/docetaxel/pemetrexed, docetaxel/pemetrexed)

    Terminated
    • Nonsmall Cell Lung Cancer
    • Fuzhou, Fujian, China
      Fuzhou general hospital
    Feb 3, 2021